Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Medigene AG is a publicly listed (Frankfurt: MDG1, Prime Standard) clinical-stage biotechnology company headquartered in Planegg/Martinsried, Germany. The company is dedicated to developing highly innovative T cell receptor (TCR) modified T cell (TCR-T) therapies to target and destroy cancer cells. Medigene's core focus lies in immuno-oncology, leveraging its proprietary TCR discovery platforms and End-to-End Platform to create differentiated TCR-T therapies for patients with solid tumors. Their approach aims to overcome the limitations of current cancer treatments by providing targeted and potent immunotherapies.
The headquarters serves as the central hub for Medigene's research and development (R&D) activities, clinical operations management, corporate administration, and strategic leadership.
Located within the Martinsried biotech cluster, providing proximity to the Max Planck Institutes, Ludwig Maximilian University of Munich (LMU) BioMedical Center, and other synergistic organizations. The facilities include modern laboratory and office spaces designed for cutting-edge biomedical research.
The work culture at Medigene's HQ is characterized by scientific rigor, innovation, collaboration, and a strong focus on translational research. Employees are typically highly skilled scientists, researchers, and professionals dedicated to advancing cancer therapies.
Its location in one of Europe's leading biotech clusters facilitates collaborations, access to a skilled workforce, and a supportive ecosystem for life science innovation. This is crucial for Medigene's mission to develop next-generation cancer treatments.
While Medigene AG's primary operations, including R&D and corporate functions, are centralized at its headquarters in Germany, its global presence is established through international collaborations, partnerships with pharmaceutical companies, and the conduct of clinical trials in multiple countries. The company targets a global market for its potential cancer therapies and actively engages with the international scientific and investment community.
Lochhamer Strasse 11
Planegg/Martinsried
Bavaria
Germany
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Medigene AG' leadership includes:
Medigene AG has been backed by several prominent investors over the years, including:
Medigene AG has strengthened its executive team with key appointments in the past 12-18 months, notably focusing on clinical development and scientific leadership to advance its TCR-T pipeline.
Discover the tools Medigene AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Medigene AG likely uses a standard corporate email format. Based on common practices and observation, the most probable format is [first_initial].[last_name]@medigene.com or [first_name].[last_name]@medigene.com.
[first_initial].[last_name]@medigene.com
Format
j.doe@medigene.com
Example
85%
Success rate
Medigene AG Press Release • May 14, 2024
Medigene AG announced its financial results for Q1 2024, highlighting progress in its TCR-T programs, including MDG1015. The company reiterated its strategic focus on advancing its pipeline and confirmed its financial guidance for 2024....more
Medigene AG Press Release • April 23, 2024
Medigene announced its participation in several key scientific and investor conferences in May 2024 to present updates on its TCR-T platform technologies and development programs, engaging with the scientific community and investors....more
Medigene AG Press Release • October 12, 2023
Medigene AG appointed Dr. Shimon Uziel as its new Chief Medical Officer (CMO), effective October 16, 2023. Dr. Uziel brings extensive experience in oncology and cell therapy clinical development to spearhead Medigene's clinical strategy and operations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Medigene AG, are just a search away.